Trial Profile
Clinical Trials Insight: 700014751
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2006
Price :
$35
*
At a glance
- Drugs Glycine-proline-glutamate (Primary)
- Indications Chronic brain damage
- Focus Therapeutic Use
- 06 Sep 2006 New trial record.